To Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic Children

• Status: Completed
• Trial end date: 2016-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this project is to evaluate in a randomized clinical trial, double-blind, controlled, the effects of a dietary supplement containing Lactobacillus reuteri DSM 17938 and vitamin D3 in reducing bronchial inflammation and improve asthma control in patients in children with mild / moderate persistent asthma .

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Second University of Naples; University of Campania "Luigi Vanvitelli"

Criteria

Inclusion Criteria:

• Patients aged between 6 and 14 years old, of both sexes

• Diagnosis of mild / moderate persistent asthma (GINA step 2/3)

• Allergy mite (Dermatophagoides farinae and pteronyssinus + + + / + + + +)

• Levels of vitamin 25 (OH) D <30 ng / ml

• Signature of the informed consent of one parent or a legal representative

Exclusion Criteria:

• Cardiovascular disease or systemic

• anatomical abnormalities

• Other respiratory diseases

• Taking probiotics and / or prebiotics in the previous 2 weeks

• Taking vitamin D or systemic corticosteroids within 4 weeks

• Participation in other clinical trials